New COVID-19 treatments study

Faculty researchers are to take part in first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness, by people in the community with COVID-19 who are at higher risk of complications.

The Platform Adaptive trial of NOvel antiviRals for eArly treatMent of COVID-19 In the Community (PANORAMIC) has been designed as a ‘platform clinical trial’, meaning it can rapidly evaluate several antiviral treatments over time that could help people at high risk of COVID-19 recover sooner, prevent the need for hospital admission and so ease the burden on the NHS.

PANORAMIC is a national priority trial, and as soon as it is set up for delivery - will be open to eligible participants from across the UK. It is being funded by the National Institute for Health Research (NIHR) and led by the University of Oxford.

Professor Paul Little, of the Faculty of Medicine and Co-Chief Investigator, said: “This trial will be one of the most ambitious ever undertaken in UK primary care, and will provide vital information about treatments to help the most vulnerable people in the ongoing fight against COVID-19.”